18
Participants
Start Date
April 16, 2021
Primary Completion Date
December 16, 2021
Study Completion Date
December 16, 2021
RJV001
Subcutaneous injection in the abdomen
Placebo
The placebo formulation has the same shape, color, and qualitative composition as the RJV001 freeze dried powder, with the exception that RJV001 drug substance has been removed. For each cohort group, a placebo will be injected in a single site in the same area as the treatment.
Study site: Arizona Research Center, Phoenix
Rejuven Dermaceutical Co., Ltd.
INDUSTRY